1 / 1

Improved Metabolic Markers in Co-Administration of Candesartan and Pioglitazone Study

This figure shows the comparison of co-administration of candesartan and pioglitazone vs. single candesartan administration on HbA1c levels in patients, with significant improvement in ⊿HMW-ADN and ⊿PAI-1. Error bars indicate SEM for both treatment arms.

tara-rollins
Download Presentation

Improved Metabolic Markers in Co-Administration of Candesartan and Pioglitazone Study

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplementary Figure 4. Co-administration vs. single candesartan After adjusted HbA1c in both patients, co-administration arm compared to candesartan administration only arm significantly improved in ⊿HMW-ADN and ⊿PAI-1 (%).*P<0.05 vsCandesartan (Can). Error bars indicate SEM for Can and for Candesartan + Pioglitazone (Can + Pio).

More Related